VIRAX IMMUNE
Live / Applied — First extension granted (statement of use) (as of 11 Mar 2026)
What this means for you
Not registered yet, but its 16 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98752797
- Mark type
- Stylized text
- Filed
- 16 Sept 2024
- Published for opposition
- 03 Jun 2025
- Attorney of record
- David W. Grace
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic kit for professional use comprised primarily of medical reagents, buffers, and assay microplates that test for the presence of cytokine-producing cells used in diagnosis and assessment of adaptive immunity
Owner
- VIRAX BIOLABS (UK) LIMITED, Lanarkshire, GB
- VIRAX BIOLABS (UK) LIMITED, Lanarkshire, GB
Prosecution history
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2026 — SOU EXTENSION 1 GRANTED
- 11 Mar 2026 — SOU EXTENSION 1 FILED
- 11 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 May 2025 — EXAMINER'S AMENDMENT ENTERED
- 01 May 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 01 May 2025 — EXAMINERS AMENDMENT E-MAILED
- 01 May 2025 — EXAMINERS AMENDMENT -WRITTEN
- 01 May 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 01 May 2025 — FINAL REFUSAL E-MAILED